Literature DB >> 2229387

Detection of Aspergillus antigens associated with invasive infection.

K A Haynes1, J P Latge, T R Rogers.   

Abstract

Serial urine samples were collected from 33 neutropenic patients, 10 of whom developed invasive aspergillosis (IA) while undergoing bone marrow transplantation or remission induction therapy for leukemia. Concentrated urine samples from the infected patients were subjected to polyacrylamide gel electrophoresis, blotted, and then incubated with antiserum raised to a cell wall extract of Aspergillus fumigatus (anti-CW) or an immunoglobulin G monoclonal antibody to A. fumigatus galactomannan (EBA1). When IA patient urine blots were probed with anti-CW, major bands at 11 and 18 kilodaltons (kDa); intermediate bands at 13, 14, and 29 kDa; and minor bands at 38 and 44 kDa were seen. In contrast, EBA1 showed diffuse staining at molecular masses larger than 45 kDa and a single weak band at 21 kDa. Urine samples from the 23 patients with no evidence of IA were unreactive with both anti-CW and EBA1. These antigen bands are likely to represent immunodominant antigens which are excreted during IA and should play a valuable role in the development of rapid diagnostic tests for aspergillosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229387      PMCID: PMC268100          DOI: 10.1128/jcm.28.9.2040-2044.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  The preparation and chemical composition of fractions from Aspergillus fumigatus wall and protoplasts possessing antigenic activity.

Authors:  V M Hearn; D W Mackenzie
Journal:  J Gen Microbiol       Date:  1979-05

2.  Aspergillosis complicating neoplastic disease.

Authors:  R D Meyer; L S Young; D Armstrong; B Yu
Journal:  Am J Med       Date:  1973-01       Impact factor: 4.965

3.  Fungemia with compromised host resistance. A study of 70 cases.

Authors:  R C Young; J E Bennett; G W Geelhoed; A S Levine
Journal:  Ann Intern Med       Date:  1974-05       Impact factor: 25.391

Review 4.  Aspergillosis. The spectrum of the disease in 98 patients.

Authors:  R C Young; J E Bennett; C L Vogel; P P Carbone; V T DeVita
Journal:  Medicine (Baltimore)       Date:  1970-03       Impact factor: 1.889

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Invasive aspergillosis. Absence of detectable antibody response.

Authors:  R C Young; J E Bennett
Journal:  Am Rev Respir Dis       Date:  1971-11

7.  Invasive aspergillosis: antiserum for circulating antigen produced after immunization with serum from infected rabbits.

Authors:  P F Lehmann; E Reiss
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

8.  Demonstration of antigenemia by radioimmunoassay in rabbits experimentally infected with Aspergillus.

Authors:  P J Shaffer; G Medoff; G S Kobayashi
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

9.  Immunodiagnosis of systemic aspergillosis. I. Antigenemia detected by radioimmunoassay in experimental infection.

Authors:  M H Weiner; M Coats-Stephen
Journal:  J Lab Clin Med       Date:  1979-01

10.  Galactomannan antigenemia in invasive aspergillosis.

Authors:  E Reiss; P F Lehmann
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

View more
  29 in total

1.  Antigen detection in invasive aspergillosis.

Authors:  K A Haynes; T R Rogers; J P Latge; R A Barnes
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

2.  Diagnosis of Paracoccidioidomycosis by detection of antigen and antibody in bronchoalveolar lavage fluids.

Authors:  Silvia Helena Marques-da-Silva; Arnaldo Lopes Colombo; Maria Heloisa Souza Lima Blotta; Flávio Queiroz-Telles; Alípio Barbosa Balthazar; José Daniel Lopes; Zoilo Pires de Camargo
Journal:  Clin Vaccine Immunol       Date:  2006-10-11

3.  Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases.

Authors:  M Weig; M Frosch; K Tintelnot; A Haas; U Gross; B Linsmeier; J Heesemann
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Detection of Aspergillus galactomannan: comparison of an enzyme-linked immunoassay and a europium-linked time-resolved fluoroimmunoassay.

Authors:  A Paugam; J Sarfati; R Romieu; M Viguier; J Dupouy-Camet; J P Latgé
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Detection of circulating Paracoccidioides brasiliensis antigen in urine of paracoccidioidomycosis patients before and during treatment.

Authors:  M A Salina; M A Shikanai-Yasuda; R P Mendes; B Barraviera; M J Mendes Giannini
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

6.  Monoclonal antibodies to hyphal exoantigens derived from the opportunistic pathogen Aspergillus terreus.

Authors:  Ajay P Nayak; Brett J Green; Erika Janotka; Justin M Hettick; Sherri Friend; Steve J Vesper; Detlef Schmechel; Donald H Beezhold
Journal:  Clin Vaccine Immunol       Date:  2011-07-06

7.  Biochemical characterization of an immunodominant allergen/antigen ofAspergillus fumigatus.

Authors:  N Bir; A Paliwal; K Muralidhar; P U Sarma
Journal:  Indian J Clin Biochem       Date:  1999-07

8.  Aspergillus Fumigatus antigen detection in sera from patients at risk for invasive aspergillosis.

Authors:  B F Chumpitazi; C Pinel; B Lebeau; P Ambroise-Thomas; R Grillot
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

9.  Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis.

Authors:  H M Miyazaki; S Kohno; Y Miyazaki; K Mitsutake; K Tomono; M Kaku; H Koga; K Hara
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

10.  Heat shock protein 88 and Aspergillus infection.

Authors:  J P Burnie; R C Matthews
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.